89bio Inc (ETNB)
8.38
+0.40
(+5.01%)
USD |
NASDAQ |
Nov 21, 16:00
8.38
0.00 (0.00%)
After-Hours: 20:00
89bio Total Assets (Quarterly): 458.30M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 458.30M |
| June 30, 2024 | 582.14M |
| March 31, 2024 | 577.32M |
| December 31, 2023 | 596.27M |
| September 30, 2023 | 460.11M |
| June 30, 2023 | 492.51M |
| March 31, 2023 | 494.32M |
| December 31, 2022 | 196.82M |
| September 30, 2022 | 200.58M |
| June 30, 2022 | 147.60M |
| March 31, 2022 | 135.76M |
| December 31, 2021 | 162.42M |
| Date | Value |
|---|---|
| September 30, 2021 | 168.06M |
| June 30, 2021 | 181.71M |
| March 31, 2021 | 198.65M |
| December 31, 2020 | 211.07M |
| September 30, 2020 | 223.43M |
| June 30, 2020 | 76.56M |
| March 31, 2020 | 87.69M |
| December 31, 2019 | 95.55M |
| September 30, 2019 | 18.35M |
| June 30, 2019 | 22.35M |
| December 31, 2018 | 11.37M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
76.56M
Minimum
Jun 2020
596.27M
Maximum
Dec 2023
287.34M
Average
199.62M
Median
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 1.073B |
| Eli Lilly and Co | 75.61B |
| Viking Therapeutics Inc | 937.89M |
| Akero Therapeutics Inc | 817.55M |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 80.20M |
| Shareholders Equity (Quarterly) | 378.10M |